Literature DB >> 19897336

Development of "extended radical retropubic prostatectomy": a surgical technique for improving margin positive rates in prostate cancer.

H Miyake1, H Fujimoto, M Komiyama, M Fujisawa.   

Abstract

AIMS: The objective of this study was to introduce a surgical approach called "extended radical retropubic prostatectomy (ERRP)" developed to reduce positive surgical margin rates in prostate cancer.
METHODS: Modified surgical procedures in ERRP included apical dissection (division of the dorsal venous complex far distal to the prostatic urethral junction), excision of the bilateral neurovascular bundles (wide resection of structure between the exterior of the urethra and the rectal surface, which contains the neurovascular bundle), perirectal dissection (complete resection of perirectal tissue by dissecting the anterior rectal surface until the muscle layer of the rectum was encountered) and seminal vesicle excision (dissection that leaves seminal vesicles protected by Denonvilliers' fascia with the surrounding fatty and fascial coverings without pulling seminal vesicles from the prostate). This study included 127 consecutive patients who did not request the preservation of potency and underwent ERRP without any neoadjuvant therapies.
RESULTS: Median value of preoperative serum prostate specific antigen in 127 patients was 18.1 ng/ml. Median operative time and estimated blood loss in these patients were 209 min and 744 ml, respectively. The pathological stage was diagnosed as pT2, pT3a, pT3b and pT4 in 51, 52, 20 and 4, respectively, while positive surgical margin was detected in 14 of the 127 patients. Furthermore, during the observation period of this study (median, 46 months), biochemical recurrence was detected in 11 of the 127 patients.
CONCLUSIONS: The ERRP technique could successfully decrease the positive surgical margin rate even in patients with comparatively adverse disease characteristics. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19897336     DOI: 10.1016/j.ejso.2009.10.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  7 in total

1.  Oncologic Outcome of Radical Prostatectomy as Monotherapy for Men with High-risk Prostate Cancer.

Authors:  Junya Furukawa; Hideaki Miyake; Taka-Aki Inoue; Takayoshi Ogawa; Hirokazu Tanaka; Masato Fujisawa
Journal:  Curr Urol       Date:  2016-05-20

2.  Comparison of semi-extended and standard lymph node dissection in radical prostatectomy: A single-institute experience.

Authors:  Senji Hoshi; Natuho Hayashi; Yuuta Kurota; Kiyotsugu Hoshi; Akinori Muto; Osamu Sugano; Kenji Numahata; Vladimir Bilim; Isoji Sasagawa; Shoichiro Ohta
Journal:  Mol Clin Oncol       Date:  2015-07-08

Review 3.  [Node-positive prostate cancer. Value of radical prostatectomy].

Authors:  A Heidenreich; A J Schrader
Journal:  Urologe A       Date:  2010-10       Impact factor: 0.639

4.  Serum early prostate cancer antigen (EPCA) level and its association with disease progression in prostate cancer in a Chinese population.

Authors:  Zhigang Zhao; Wenjing Ma; Guohua Zeng; Defeng Qi; Lili Ou; Yeping Liang
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

5.  Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer.

Authors:  Shintaro Narita; Norihiko Tsuchiya; Teruaki Kumazawa; Shinya Maita; Kazuyuki Numakura; Takashi Obara; Hiroshi Tsuruta; Mitsuru Saito; Takamitsu Inoue; Yohei Horikawa; Shigeru Satoh; Hiroshi Nanjyo; Tomonori Habuchi
Journal:  World J Surg Oncol       Date:  2012-01-04       Impact factor: 2.754

Review 6.  Utility of Lymphadenectomy in Prostate Cancer: Where Do We Stand?

Authors:  Bartosz Małkiewicz; Paweł Kiełb; Jakub Karwacki; Róża Czerwińska; Paulina Długosz; Artur Lemiński; Łukasz Nowak; Wojciech Krajewski; Tomasz Szydełko
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.241

7.  Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection.

Authors:  Eijiro Okajima; Motokiyo Yoshikawa; Yasumasa Masuda; Kazuhiro Shimizu; Nobumichi Tanaka; Akihide Hirayama; Keiji Shimada; Kiyohide Fujimoto; Yoshihiko Hirao
Journal:  World J Surg Oncol       Date:  2012-11-16       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.